Results

Total Results: 3,847 records

Showing results for "topical treatment".

321. USPSTF Analytic Framework for Child and Adolescent Health Topics | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/methods-and-processes/uspstf-analytic-framework-child-and-adolescent-health-topics
     October 01, 2017 - example, identifying low- and high-risk populations, or recording normal and abnormal test results) and treatment … Are effective treatments available that make a difference in intermediate outcomes when the disease is … What are the harms of the treatment?

322. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nUKZWGKL2FA2Z5fZ3eCrDU
     November 22, 2023 - affected teeth or surfaces), morbidity, quality of life, functional status, and harms of screening or treatment … −1.30 to −0.19]).1,31 Similarly, in a systematic review (26 trials)19 evaluating applica- tion of topical … 48%; P < .001) and in first permanent molars (86% vs 67%; P < .001).1,31 Studies reported that SDF treatment … ADA clinical recommendations on topical fluoride for caries prevention. … Fluoride therapy. In: The Reference Manual of Pediatric Dentistry.

323. Opioid Use Disorder News—2019 Updates | The Academy
     integrationacademy.ahrq.gov/news-and-events/news/opioid-use-disorder-news-2019-updates
     October 04, 2019 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations … Innovative Approaches Can Help Improve Availability of Opioid Use Disorder Treatment (PDF--475 KB)   … This brief from the Pew Charitable Trusts describes promising innovative treatment models that aim to

324. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
     November 01, 2014 - Potential harms also include side effects or complications of treatments. … Long-term harms of HIV antiretroviral therapy. Sexually transmitted infections 2. … inhibitors and complementary or alternative treatments). … Studies on the effectiveness of antiretroviral therapy, adherence to treatment, and behavioral counseling … Ophthalmia Neonatorum: Preventive Medication for Newborns The USPSTF recommends prophylactic ocular topical

325. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
     November 01, 2014 - Potential harms also include side effects or complications of treatments. … Long-term harms of HIV antiretroviral therapy. Sexually transmitted infections 2. … inhibitors and complementary or alternative treatments). … Studies on the effectiveness of antiretroviral therapy, adherence to treatment, and behavioral counseling … Ophthalmia Neonatorum: Preventive Medication for Newborns The USPSTF recommends prophylactic ocular topical

326. Behavioral Health Integration Gets Historic Funding | The Academy
     integrationacademy.ahrq.gov/news-and-events/news/behavioral-health-integration-gets-historic-funding
     September 23, 2024 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … Health Care Programs (9/10/24) Funding to Integrate Primary and Behavioral Health Care, and Expand Drug Treatment … Court Capacity (8/29/24) Awards and Funding Opportunities for Prevention, Treatment, and Workforce … seeks further congressional action to secure this expansion of mental health and substance use disorder treatment

327. Primary Care MAT Opioid Use Disorder Grantees | The Academy
     integrationacademy.ahrq.gov/about/initiatives/opioid/grantees
     June 01, 2022 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … Primary Care Practices , to support rural primary care practices in delivering medication-assisted treatment … New Mexico “ECHO-F Model to Expand Medication Assisted Treatment in Rural Primary Care,” University … These grantees hope to improve access to treatment in rural areas by increasing the number of primary

328. Integrating Behavioral Health & Primary Care| AHRQ Academy
     integrationacademy.ahrq.gov/
     January 01, 2013 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … Healthcare Initiatives NIH HEAL Initiative – Overdose Resources Announced Substance Use Disorder Treatment … Healthcare Initiatives NIH HEAL Initiative – Overdose Resources Announced Substance Use Disorder Treatment … Playbooks Follow guidance on how to integrate behavioral health and medication-assisted treatment

329. Integrating Behavioral Health & Primary Care| AHRQ Academy
     integrationacademy.ahrq.gov/
     January 01, 2013 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … Healthcare Initiatives NIH HEAL Initiative – Overdose Resources Announced Substance Use Disorder Treatment … Healthcare Initiatives NIH HEAL Initiative – Overdose Resources Announced Substance Use Disorder Treatment … Playbooks Follow guidance on how to integrate behavioral health and medication-assisted treatment

330. Statistical Brief #133
     hcup-us.ahrq.gov/reports/statbriefs/sb133.jsp
     May 01, 2012 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … transluminal coronary angioplasty (PTCA) upper gastrointestinal endoscopy (with or without biopsy) treatment … stay, -.6%; nonelderly stays per population, 1.5%; cost per day, 3.1%; nonelderly population, 1.0%; Treatment … ultrasound of heart (echocardiogram); 3.5%, Alcohol and drug rehabilitation/detoxification; 3.1% , Treatment … However, if a patient received long-term care, rehabilitation, or treatment for psychiatric or chemical

331. Health Equity | Agency for Healthcare Research and Quality
     www.ahrq.gov/ncepcr/reports/2024-annual-report/recent-grants-health-equity.html
     May 01, 2024 - Preventive Care for Children P12: Using a Televideo-based Training Model for Providers to Expand Treatment … Multi-State, Mixed-Methods Evaluation of the Uptake of New Direct  Acting Antiviral Regimens for the Treatment … Worcester Uses claims analyses to examine uptake of newer and more effective direct-acting antiviral (DAA) treatment … The research team will also identify the patient, provider, and contextual factors that predict DAA treatment … in six categories in the report: patient safety, patient-centered care, care coordination, effective treatment

332. Substance Use Resources | The Academy
     integrationacademy.ahrq.gov/products/substance-use-resources
     January 01, 2016 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … Primary Care Medication-Assisted Treatment Grantees In 2016, AHRQ invested in a grant initiative … MAT for OUD Playbook The AHRQ Academy developed the Medication-Assisted Treatment for Opioid Use

333. Federal Interagency Workgroup on Improving Diagnostic Safety--March Meeting Summary (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/topics/DxSafety-March2019-MeetingNotes.pdf
     March 08, 2019 - /NCI • Program Announcements for: Using Information Technology to Support Systematic Screening and Treatment … Home Reference to help patients understand their diagnoses and how to navigate the disease and the treatment … DOD • Deep-dive analysis of treatment delays that result in significant errors. … • Partnership with VA to look at data, trends, and solution for delay in treatment event type.

334. Comments Due September 9 for New CMS Proposed Rule | The Academy
     integrationacademy.ahrq.gov/news-and-events/news/comments-due-september-9-new-cms-proposed-rule
     July 31, 2024 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … The proposed rule also calls for reimbursement for digital mental health treatment and the extension

335. Interview Guide to Assess Targeting Medication Nonadherence Using Mobile Phone Messages (pdf file)
     digital.ahrq.gov/sites/default/files/docs/survey/interview-guide-to-assess-targeting-medication-nonadherence-using-mobile-phone-messages.pdf
     June 16, 2021 - Did you enjoy receiving messages on your phone specific to your condition and treatment? a. … Did you find the information in these messages helpful in your ongoing treatment? a. … If you were to continue to receive messages on your phone about your treatment and/or condition, what … The messages you received were created specifically for you, meaning they were tailored to your treatment … future, would you consider receiving tailored messages on your phone throughout the course of your treatment

336. Overdose of Gabapentin and Oxycodone in a Patient with End-Stage Renal Disease: A Case for Appropriate Interruptive Drug-Disease Alerts. | PSNet
     psnet.ahrq.gov/web-mm/overdose-gabapentin-and-oxycodone-patient-end-stage-renal-disease-case-appropriate
     June 24, 2020 - Oxycodone is considered a second-line therapy compared with other opioids and may be used with caution … including baclofen, tizanidine, cyclobenzaprine, and methocarbamol, are commonly used as adjunctive treatments … Topical NSAIDs such as diclofenac gel have reduced systemic absorption compared to their oral counterparts … As such, topical agents should be considered in patients with CKD, especially in patients with musculoskeletal … patient-specificinformation, usually at the point of care, to help inform decisions about a patient's treatment

337. Statistical Brief #31
     hcup-us.ahrq.gov/reports/statbriefs/sb31.jsp
     May 01, 2007 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … The length of stay and cost for treatment was similar across most payer types. … DRGs group patients according to diagnosis, type of treatment (procedures), age, and other relevant criteria

338. Timeline for Implementing Antibiotic Stewardship in Ambulatory Care (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/timeline.docx
     September 01, 2022 - Best Practices in the Diagnosis and Treatment of Cellulitis and Skin and Soft Tissue Abscesses Presentation … Best Practices in the Diagnosis and Treatment of Asymptomatic Bacteriuria and Urinary Tract Infections

339. Statistical Brief #26
     hcup-us.ahrq.gov/reports/statbriefs/sb26.jsp
     February 01, 2007 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … Statistical Brief presents data from the Healthcare Cost and Utilization Project (HCUP) on the hospital treatment … In 2004, the mean length of stay for the treatment of a circulatory disease was 4.5 days, which was the

340. Outcomes and Objectives Workgroup: Patient-Focused Outcome Measures for Patient-Centered CDS (pdf file)
     cdsic.ahrq.gov/sites/default/files/2023-10/Final%20OO%20Patient%20Outcomes%20of%20PC%20CDS%20to%20AHRQ%2010.6.23.pdf
     January 01, 2023 - Decision Quality is “the extent to which treatments reflect the considered preferences of well-informed … Adherence to Long-term Therapies Evidence for Action. Ann Saudi Med. 2004;24(3):221-222. … automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy … risk decision support in primary care: Computerization of Medical Practices for the Enhancement of Therapeutic … Drivers of Emergency Department Use Among Oncology Patients in the Era of Novel Cancer Therapeutics: